Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Umberto Ricardi, MD, University of Turin, Turin, Italy, talks on the importance of identifying prognostic factors and biomarkers in patients with lung cancer and brain metastases in order to optimize treatment. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.